Generation Bio Co.
GBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $9 | $4 |
| % Growth | 108.4% | -91.2% | 108.3% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $9 | $4 |
| % Margin | 11.9% | 100% | 100% | 100% |
| R&D Expenses | $14 | $15 | $15 | $15 |
| G&A Expenses | $0 | $8 | $9 | $9 |
| SG&A Expenses | $8 | $8 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $1 | $4 |
| Operating Expenses | $22 | $24 | $25 | $28 |
| Operating Income | -$21 | -$23 | -$17 | -$24 |
| % Margin | -1,348.7% | -2,995.6% | -190.4% | -562.6% |
| Other Income/Exp. Net | $16 | $2 | $2 | $2 |
| Pre-Tax Income | -$6 | -$21 | -$15 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$21 | -$15 | -$21 |
| % Margin | -346.3% | -2,735% | -169.7% | -510.6% |
| EPS | -0.82 | -3.12 | -2.21 | -3.2 |
| % Growth | 73.7% | -41.2% | 30.9% | – |
| EPS Diluted | -0.82 | -3.12 | -2.21 | -3.2 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$4 | -$21 | -$14 | -$19 |
| % Margin | -258.2% | -2,780.1% | -164.3% | -448.6% |